![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Croxtall Jamie D. Lyseng-Williamson Katherine A.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.70, Iss.4, 2010-03, pp. : 479-488
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Terguride for pulmonary arterial hypertension
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sitaxentan: In Pulmonary Arterial Hypertension
Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dasatinib linked to pulmonary arterial hypertension
Reactions Weekly, Vol. 1, Iss. 1368, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)